Metformin Use Linked to Lower Odds of Myeloproliferative Neoplasms
Authors note that primary prophylaxis prevention is not feasible due to rarity of MPN
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Authors note that primary prophylaxis prevention is not feasible due to rarity of MPN
Only registered members have full access to PracticeUpdate content.